TRANSPEK Latest Share Price (TRANSPEK)
TODAY IN ONE LINE
With a market cap of ₹697.64 Cr., it trades at a P/E of 19.93. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
TRANSPEK flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Reasonable ValuationTrading at a moderate P/E of 12.4x
- ●High Promoter HoldingPromoters hold 57.3% skin-in-the-game
- ●Steady Dividend YieldReliable 1.54% dividend yield
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.06x
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Poor Capital ReturnsLow ROE of 6.0%
Latest TRANSPEK News
What changed recently?
Recent events, corporate actions, and announcements.
TRANSPEK valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for TRANSPEK, framed against the sector median so the premium or discount is obvious at a glance.
TRANSPEK trades at a P/E of 19.93× and P/B of 1.01×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
TRANSPEK technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for TRANSPEK — derived from the latest tape, not yesterday's close.
TRANSPEK last traded at ₹1,232.6 with an intraday range of ₹1,192.1–₹1,280 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹1232.60| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 1453.50 | +220.90 | +17.92% |
| R3 | 1365.60 | +133.00 | +10.79% |
| R2 | 1322.80 | +90.20 | +7.32% |
| R1 | 1277.70 | +45.10 | +3.66% |
| PIVOT | 1234.90 | 2.30 | 0.19% |
| CURRENT | 1232.60 | — | — |
| S1 | 1189.80 | -42.80 | -3.47% |
| S2 | 1147.00 | -85.60 | -6.94% |
| S3 | 1101.90 | -130.70 | -10.60% |
| S4 | 1014.00 | -218.60 | -17.73% |
TRANSPEK is trading Below CPR, indicating Bearishness
CPR is Average
Day's range: ₹–₹
Trading Inside opening range
TRANSPEK financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for TRANSPEK — consolidated or standalone — with margins, YoY growth and key ratios inline.
TRANSPEK reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹697.64 Cr. and reported EPS of ₹15.98.
| Metric | Mar 2026 | May 2026 |
|---|---|---|
| Revenue from Operations | 621 | 621 ▲ 0.0% |
| Sales Growth YoY %Derived | -4.41% | -4.41% |
| Other Income | 25 | 25 ▲ 0.0% |
| Total Income | 646 | 646 ▲ 0.0% |
| 291 | 291 ▲ 0.0% | |
| Gross ProfitDerived | 331 | 331 ▲ 0.0% |
| Gross Margin %Derived | 53.22% | 53.22% |
| 237 | 237 ▲ 0.0% | |
| EBITDA (Operating Profit)Derived | 93 | 93 ▲ 0.0% |
| OPM %Derived | 15.03% | 15.03% |
| 57 | 57 ▲ 0.0% | |
| Profit Before Tax (PBT) | 61 | 61 ▲ 0.0% |
| 16 | 16 ▲ 0.0% | |
| Effective Tax %Derived | 25.41% | 25.41% |
| Total Profit for Period | 46 | 46 ▲ 0.0% |
| Net Profit (Owner's PAT)Derived | 46 | 46 ▲ 0.0% |
| Net Profit Margin %Derived | 7.35% | 7.35% |
| PAT Growth YoY %Derived | -6.34% | -6.34% |
| Earnings Per Share (EPS ₹) | 81.72 | 81.72 ▲ 0.0% |
| Diluted Shares Outstanding (Cr) | 1 | 1 ▲ 0.0% |
| Other Comprehensive Income (Net of Tax) | -12 | -12 ▲ 0.0% |
| Total Expenses (incl. D&A & Interest) | 585 | 585 ▲ 0.0% |
| Material Cost % of RevenueDerived | 45.01% | 45.01% |
| Employee Cost % of RevenueDerived | 11.79% | 11.79% |
| Other Cost % of RevenueDerived | 26.39% | 26.39% |
| Interest Coverage (x)Derived | 5.55x | 5.55x |
| Period | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | May 2025 | Mar 2026 | May 2026 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 595 | 566 ▼ 4.9% | 339 ▼ 40.0% | 599 ▲ 76.5% | 827 ▲ 38.0% | 580 ▼ 29.9% | 650 ▲ 12.1% | 650 ▲ 0.0% | 621 ▼ 4.4% | 621 ▲ 0.0% | |
| Sales Growth YoY %Derived | — | -4.87% | -40.00% | 76.52% | 38.02% | -29.90% | 12.12% | — | -4.41% | -4.41% | |
| Other Income | 18 | 17 ▼ 2.3% | 17 ▼ 0.7% | 28 ▲ 64.4% | 18 ▼ 37.3% | 25 ▲ 41.3% | 29 ▲ 14.1% | 29 ▲ 0.0% | 25 ▼ 14.6% | 25 ▲ 0.0% | |
| Total Income | 612 | 583 ▼ 4.8% | 357 ▼ 38.8% | 627 ▲ 75.9% | 845 ▲ 34.6% | 605 ▼ 28.4% | 679 ▲ 12.2% | 679 ▲ 0.0% | 646 ▼ 4.8% | 646 ▲ 0.0% | |
301 | 260 ▼ 13.5% | 163 ▼ 37.6% | 315 ▲ 93.6% | 438 ▲ 39.2% | 287 ▼ 34.4% | 332 ▲ 15.7% | 332 ▲ 0.0% | 291 ▼ 12.6% | 291 ▲ 0.0% | ||
| Gross ProfitDerived | 294 | 305 ▲ 4.0% | 177 ▼ 42.1% | 284 ▲ 60.9% | 389 ▲ 36.7% | 292 ▼ 24.9% | 317 ▲ 8.6% | 317 ▲ 0.0% | 331 ▲ 4.2% | 331 ▲ 0.0% | |
| Gross Margin %Derived | 49.38% | 53.97% | 52.10% | 47.47% | 47.03% | 50.42% | 48.84% | 48.84% | 53.22% | 53.22% | |
177 | 187 ▲ 5.9% | 130 ▼ 30.8% | 188 ▲ 45.3% | 242 ▲ 28.3% | 210 ▼ 13.1% | 223 ▲ 6.1% | 223 ▲ 0.0% | 237 ▲ 6.5% | 237 ▲ 0.0% | ||
| EBITDA (Operating Profit)Derived | 117 | 118 ▲ 1.1% | 47 ▼ 60.0% | 96 ▲ 103.7% | 147 ▲ 53.2% | 82 ▼ 44.1% | 95 ▲ 15.0% | 95 ▲ 0.0% | 93 ▼ 1.4% | 93 ▲ 0.0% | |
| OPM %Derived | 19.61% | 20.84% | 13.90% | 16.04% | 17.81% | 14.20% | 14.57% | 14.57% | 15.03% | 15.03% | |
33 | 42 ▲ 26.1% | 39 ▼ 6.8% | 40 ▲ 3.5% | 52 ▲ 29.8% | 52 ▼ 0.6% | 62 ▲ 18.8% | 62 ▲ 0.0% | 57 ▼ 8.2% | 57 ▲ 0.0% | ||
| Profit Before Tax (PBT) | 101 | 94 ▼ 7.7% | 26 ▼ 72.7% | 84 ▲ 230.0% | 113 ▲ 33.9% | 56 ▼ 50.8% | 62 ▲ 11.1% | 62 ▲ 0.0% | 61 ▼ 0.7% | 61 ▲ 0.0% | |
36 | 21 ▼ 42.2% | 2 ▼ 89.2% | 19 ▲ 744.9% | 29 ▲ 55.6% | 17 ▼ 42.2% | 13 ▼ 23.8% | 13 ▲ 0.0% | 16 ▲ 20.4% | 16 ▲ 0.0% | ||
| Effective Tax %Derived | 35.11% | 22.00% | 8.73% | 22.36% | 25.99% | 30.54% | 20.95% | 20.95% | 25.41% | 25.41% | |
| Total Profit for Period | 66 | 73 ▲ 11.0% | 23 ▼ 68.1% | 65 ▲ 180.7% | 83 ▲ 27.6% | 39 ▼ 53.8% | 49 ▲ 26.4% | 49 ▲ 0.0% | 46 ▼ 6.3% | 46 ▲ 0.0% | |
| Net Profit (Owner's PAT)Derived | 66 | 73 ▲ 11.0% | 23 ▼ 68.1% | 65 ▲ 180.7% | 83 ▲ 27.6% | 39 ▼ 53.8% | 49 ▲ 26.4% | 49 ▲ 0.0% | 46 ▼ 6.3% | 46 ▲ 0.0% | |
| Net Profit Margin %Derived | 11.06% | 12.90% | 6.87% | 10.92% | 10.10% | 6.65% | 7.50% | 7.50% | 7.35% | 7.35% | |
| PAT Growth YoY %Derived | — | 10.97% | -68.06% | 180.69% | 27.64% | -53.81% | 26.40% | — | -6.34% | -6.34% | |
| Earnings Per Share (EPS ₹) | 117.70 | 130.60 ▲ 11.0% | 41.71 ▼ 68.1% | 117.09 ▲ 180.7% | 149.45 ▲ 27.6% | 69.03 ▼ 53.8% | 87.26 ▲ 26.4% | 87.26 ▲ 0.0% | 81.72 ▼ 6.3% | 81.72 ▲ 0.0% | |
| Diluted Shares Outstanding (Cr) | 1 | 1 ▲ 0.0% | 1 ▲ 0.0% | 1 ▲ 0.0% | 1 ▲ 0.0% | 1 ▲ 0.0% | 1 ▲ 0.0% | 1 ▲ 0.0% | 1 ▲ 0.0% | 1 ▲ 0.0% | |
| Other Comprehensive Income (Net of Tax) | 5 | -26 ▼ 636.5% | 19 ▲ 175.7% | 43 ▲ 122.5% | 31 ▼ 27.4% | 64 ▲ 102.2% | 31 ▼ 51.2% | 31 ▲ 0.0% | -12 ▼ 139.8% | -12 ▲ 0.0% | |
| Total Expenses (incl. D&A & Interest) | 511 | 490 ▼ 4.2% | 331 ▼ 32.4% | 543 ▲ 64.1% | 732 ▲ 34.7% | 549 ▼ 25.0% | 617 ▲ 12.3% | 617 ▲ 0.0% | 585 ▼ 5.3% | 585 ▲ 0.0% | |
| Material Cost % of RevenueDerived | 51.18% | 44.75% | 46.95% | 55.56% | 53.40% | 50.70% | 50.83% | 50.83% | 45.01% | 45.01% | |
| Employee Cost % of RevenueDerived | 7.61% | 8.74% | 13.22% | 8.60% | 7.29% | 10.62% | 10.25% | 10.25% | 11.79% | 11.79% | |
| Other Cost % of RevenueDerived | 22.16% | 24.40% | 24.97% | 22.83% | 21.93% | 25.59% | 24.02% | 24.02% | 26.39% | 26.39% | |
| Interest Coverage (x)Derived | 5.40x | 5.80x | 1.79x | 6.30x | 5.94x | 3.11x | 3.81x | 3.81x | 5.55x | 5.55x |
TRANSPEK segment analysis : revenue and profit mix.
Disclosed business segments at TRANSPEK with their share of revenue and profit, switchable between consolidated and standalone reporting.
TRANSPEK discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for TRANSPEK.
Our AI distills the core fundamental drivers supporting TRANSPEK, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
What you're getting.
No strengths or opportunities on record.
Key Risks.
No weaknesses or threats on record.
Flip Conditions.
Valuation risk. a P/E above 26 would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Return-quality risk. ROE below 8% would indicate weaker capital compounding.
Income thesis breaks if the dividend is cut or yield falls below 0.77%.
TRANSPEK peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — TRANSPEK is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
TRANSPEK chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for TRANSPEK — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
TRANSPEK delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for TRANSPEK over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in TRANSPEK stood at 54.4% of traded volume, against a 20-day average of 57.0%.
TRANSPEK announcements: results, concalls, ratings, M&A.
Filings TRANSPEK sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
TRANSPEK files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 76 documents below.
Insider Trading / SAST
Notice of closure of trading window.
AGM/EGM
Proceedings under Regulation 30 of SEBI Listing Regulations, 2015.
Investor decks & rating reports.
Company Update
Company Update
Company Update
Company Update
Company Update
Company Update
Company Update
Others
Company Update
Company Update
Company Update
TRANSPEK dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue TRANSPEK has declared, sequenced by announce and record date.
TRANSPEK corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About TRANSPEK: business, sector, key facts.
What TRANSPEK does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
TRANSPEK is a listed Indian equity, listed as NSE: TRANSPEK, BSE: 506687.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- ADVANCE AGROLIFE (ADVANCE) Share PricePeer
- AGRO PHOS INDIA (AGROPHOS) Share PricePeer
- ALUFLUOR (ALUFLUOR) Share PricePeer
- AMAL (AMAL) Share PricePeer
- ARCL ORGANICS (ARCL) Share PricePeer
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about TRANSPEK (TRANSPEK).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of TRANSPEK (TRANSPEK)?
The current share price of TRANSPEK (TRANSPEK) is ₹1,232.60. Today, the stock has declined by ₹29.80 (2.36%), trading in a range of ₹1,192.10 to ₹1,280.00. The stock opened at ₹1,222.00 with a trading volume of 5,657 shares.
02Is TRANSPEK stock a good investment for long-term?
TRANSPEK can be considered for long-term investment based on several factors. The company has a market capitalization of ₹697.64 Cr., P/E ratio of 19.93, ROE of 5.95%, and ROCE of 6.87%. The dividend yield stands at 1.54%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of TRANSPEK stock?
The 52-week high price of TRANSPEK (TRANSPEK) is ₹1,447.90, while the 52-week low is ₹952.30. Currently trading at ₹1,232.60, the stock is 29.43% above its 52-week low and 14.87% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy TRANSPEK stock at the current price?
Whether to buy TRANSPEK stock at ₹1,232.60 depends on multiple factors. The stock is currently trading with a P/E ratio of 19.93 and P/B ratio of 1.01. Today's performance shows a loss of 2.36%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of TRANSPEK and when is the next dividend?
TRANSPEK offers a dividend yield of 1.54%, which means for every ₹100 invested at the current price of ₹1,232.60, you can expect to receive approximately ₹1.54 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of TRANSPEK?
TRANSPEK's key financial metrics include: P/E Ratio: 19.93, P/B Ratio: 1.01, ROE: 5.95%, ROCE: 6.87%, Dividend Yield: 1.54%, EPS: ₹15.98, Book Value: ₹1,373.97, and Debt-to-Equity: 0.06. The company's market cap stands at ₹697.64 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is TRANSPEK stock performing today in the market?
TRANSPEK stock opened at ₹1,222.00 and is currently trading at ₹1,232.60, showing a decline of ₹29.80 (2.36%). The intraday high is ₹1,280.00 and low is ₹1,192.10. The trading volume stands at 5,657 shares, indicating moderate market participation today.
08What is the P/E ratio of TRANSPEK and what does it indicate?
TRANSPEK has a Price-to-Earnings (P/E) ratio of 19.93, which means investors are willing to pay 19.93 for every ₹1 of earnings. With an EPS of ₹15.98, this P/E ratio indicates moderate valuation in line with market standards. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about TRANSPEK (TRANSPEK) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.